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Abstract
 .P-Glycoprotein P-gp is a 180-kDa membrane-bound transporter which can confer the multi-drug resistance phenotype
on tumor cells. We have examined the factors required to preserve activity of P-gp during its purification. The starting
 r .material for purification was plasma membranes from Chinese hamster ovary CH B30 cells, overexpressing P-glyco-
 y1 y1protein. These membranes displayed drug stimulated ATPase activity V s897"55 nmol min mg ; K s1.8"0.4m m
. w3 x  .mM and high affinity binding of H vinblastine K s36"5 nM; B s161"11 pmolrmg . Several non-ionicd m
detergents which readily solubilized P-glycoprotein significantly inhibited ATPase activity and drug binding at concentra-
tions well below their respective CMC values. This inactivation was prevented by excess crude lipid mixtures, with the
greatest protection afforded against dodecyl-maltoside. Furthermore, the significantly reduced binding affinity and capacity
of solubilized P-gp was partly reversed by the addition of lipids. A combination of anion-exchange and hydroxyapatite
chromatography were used to purify P-gp with high yield to greater than 90%. The purified, reconstituted P-gp displayed
 .  .high ATPase activity V s2137"309; K s2.9"0.9 mM which was stimulated by verapamil EC s3.8"0.6 mMm m 50
 . and inhibited by orthovanadate 3.1"0.8 mM . Pure P-gp also displayed high affinity vinblastine binding K s64"9d
.nM with a capacity of 2320"192 pmolrmg. This purification scheme yields the highest P-gp activity reported to date,
and indicates a dependence of function on maintaining a lipid–protein interface. q 1997 Elsevier Science B.V.
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1. Introduction
The development of a multiple-drug resistance
 .MDR phenotype frequently results in the failure of
chemotherapeutic treatment of neoplastic disorders.
An important factor in MDR is the 180-kDa mem-
 . w xbrane-bound P-glycoprotein P-gp 1,2 . P-gp is
thought to confer drug resistance by maintaining low
0005-2736r97r$17.00 q 1997 Elsevier Science B.V. All rights reserved.
 .PII S0005-2736 97 00079-5
( )R. Callaghan et al.rBiochimica et Biophysica Acta 1328 1997 109–124110
cellular levels of chemotherapeutic drugs in tumor
cells. The protein is also expressed in many normal
w xtissues 3 and belongs to a large group of eukaryotic
and prokaryotic membrane proteins known as the
w xABC superfamily 4 . P-gp is post-translationally
w xmodified by phosphorylation 5 in the highly charged
‘linker’ region and glycosylation in the first extracel-
w xlular loop 6 . However, it appears that neither phos-
w x w xphorylation, 7,8 nor glycosylation 6 affects the
ability of P-gp to confer multi-drug resistance.
A large number of unrelated compounds specifi-
w xcally bind or label P-gp 9 in its native environment.
In addition, membranes containing P-gp display high
levels of ATP hydrolytic activity which is altered by
w xseveral P-gp substrates 10,11 . The precise mecha-
nism by which ATP hydrolysis and substrate binding
are coupled to facilitate transport remains unclear.
The conventional model in which P-gp contains a
 .distinct binding site s with a localised conforma-
tional change leading to substrate reorientation across
the bilayer, as demonstrated for several other mem-
w xbrane transporters may be envisioned 12 . However,
to account for the broad substrate specificity of P-gp,
some novel transport models have been proposed
w x13–15 . For example, the hydrophobic vacuum model
proposes that a non-selective hydrophobic surface on
P-gp is used to accept the wide range of substrates
whose only consistent link is their hydrophobicity.
w xHowever, the majority of pharmacological 16–18 ,
w x w xmutational 19 and photo labeling data 20 support a
conventional transport model in which multiple spe-
cific drug acceptor sites accessible from the cyto-
plasm are found on P-gp.
In order to address the mechanisms of P-gp-media-
ted drug transport, including turnover number, multi-
plicity of binding sites, coupling of ATP hydrolysis
to transport and to obtain structural data, the purifica-
tion of functional P-gp is required. Several purifica-
tion procedures have been developed for P-gp, result-
ing in protein ranging from 20 to 90% purity. Among
 .the methods used are: 1 immunoaffinity chromatog-
w x  . w x  .raphy 21 ; 2 selective detergent extraction 22 ; 3
w x  .ion-exchange chromatography 23 ; 4 affinity chro-
w xmatography 24 and various combinations of these
w x25,26 . However, in several of these procedures the
specific P-gp activity did not increase above levels in
the starting material, reflecting significant levels of
inactivation. It has been proposed that interaction of
P-gp with several chromatographic matrices is a ma-
w xjor cause of inactivation 26,27 .
The first step in purification of an integral mem-
brane protein involves extraction from its lipid envi-
ronment, usually by detergents. P-gp appears to be
influenced by its membrane environment. In particu-
 .lar, 1 expression of P-gp tends to ‘destabilize’ the
w x  .plasma membrane 28,29 , 2 modification of lipid
composition or biophysical properties alters P-gp ac-
w x  .tivity 30,31 , and 3 the ATPase activity of soluble
w xP-gp is affected by several phospholipids 26 . There-
fore the delipidation of proteins which can occur
during solubilization and chromatographic separation
w x32 may have significant consequences for the func-
tional integrity of P-gp.
In the present study, we have investigated the
solubilization and chromatographic conditions that
retain maximal drug binding and ATP hydrolyzing
activity of P-gp. It was concluded that disruption of
the lipid–protein interface is a major factor responsi-
ble for inactivation of P-gp during purification. The
resulting purification scheme generated P-gp with
significantly increased ATPase activity and drug
binding capacity compared with the starting material.
2. Materials and methods
2.1. Materials
w3 x  .H Vinblastine sulfate 13.5 Cirmmol , and
w3 x  .H phosphatidyl choline 62 Cirmmol were pur-
 .chased from Amersham Amersham, UK . Hydroxya-
 .  .patite CHT-II and anion-exchange Q Econo-Pac
 .prepacked chromatography columns 1 ml and the
Detergent Compatible protein assay kit were from
 .Bio-Rad Hemel Hempstead, UK . Bovine serum al-
 .  .bumin )95% pure , g-globulin )95% pure ,
ascorbate, verapamil hydrochloride, orthovanadate
 .and molybdate were from Sigma Poole, UK . GFrF
glass fiber, 0.1 and 0.2 mm nitrocellulose filters and
 .crude soya bean lipids asolectin were obtained from
 .BDH Poole, UK . The Rapid-Ag silver stain kit was
 .purchased from ICN chemicals Thame, UK , and
bovine spinal cord lipid extract from Lipid Products
 .Surrey, UK . The detergents dodecyl-b-D-
maltopyranoside, octyl-b-D-glucoside and zwittergent
3–12 were purchased from Calbiochem Nottingham,
.UK .
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2.2. Plasma membrane preparations
CH rB30 cells were grown as described previously
in media supplemented with 30 mgrml colchicine
w x r1 . Preparation of plasma membranes from CH B30
cells was based on previously published methods
w x r  9.33 . Briefly, CH B30 cells 1=10 were sus-
pended to a density of 2.5=107 cellsrml and sub-
 .jected to two rounds of N cavitation 20 min at2
1000 p.s.i. and 48C. Following the final centrifuga-
tion, the membranes were resuspended at a protein
concentration of 5–7 mgrml and stored at y808C for
up to 6 months.
2.3. P-gp purification procedure
Frozen plasma membranes were rapidly thawed
and collected by centrifugation at 150 000=g for 40
min. The pellet was resuspended at a protein concen-
tration of 5 mgrml in low ionic strength buffer A
  .18% vrv glycerol, 10 mM PIPES, pH 6.9, 1 mM
.  .EDTA, 0.02% NaN , containing 0.2% wrv soni-3
 .cated bovine spinal cord lipids and 0.4% wrv
dodecyl-maltoside. This mixture was incubated at
48C for 30 min and subsequently centrifuged at
100 000=g for 20 min. The supernatant containing
solubilized P-gp was injected onto a 1-ml Q-column
previously equilibrated with buffer A containing
 .0.02% wrv dodecyl-maltoside. The column was
washed with 4-vols. of buffer A and then subjected to
a linear gradient of NaCl to reach 1 M over 20 min 2
.mlrmin flow rate . P-gp eluted in the void volume
under the above conditions. The appropriate fractions
were concentrated using 100 kDa molecular weight
 .cut-off Centricon 100 Amicon filters centrifuged at
500=g until a protein concentration of 0.25–0.35
mgrml was achieved. This concentrated post-anion-
exchange protein solution was then loaded onto an
 .hydroxy-apatite column 1 ml previously equili-
brated with buffer C 15 mM NaP , pH 6.6, 0.02%i
 . .wrv dodecyl-maltoside . Proteins bound to the ma-
trix were eluted with a linear gradient to 500 mM
 .NaP in buffer C over 36 min 0.8 mlrmin flow rate .i
Samples containing P-gp were detected using SDS–
PAGE and concentrated to 0.3–0.4 mgrml using
Centricon 100 filters by centrifugation at 500=g.
2.4. Reconstitution procedures
P-gp was reconstituted into preformed unilamellar
 .vesicles LUVs made by extrusion of multi-lamellar
vesicles through 200 nm nitrocellulose filters as de-
w xscribed previously 34 . Electron microscopic evi-
dence has confirmed the unilamellar nature of these
 .liposomes data not shown . To determine conditions
at which the liposomes were completely solubilized
w xor saturated with detergent 35 , the LUVs were
progressively solubilized with octyl-glucoside.
Briefly, LUVs were resuspended at concentrations of
2.5, 5, 10, 12.5, 15, 20 and 25 mM in a total volume
of 500 ml dialysis buffer D 150 mM NaCl, 10 mM
.Tris HCl, pH 7.4, 1 mM EDTA, 1 mM benzamidine .
Increasing concentrations of octyl-glucoside were then
added until light scattering at 750 nm by the LUVs
was relieved, reflecting a micellar suspension of lipid
and detergent. An equilibration period of 2–4 min
 .allowing equilibration of the signal was used at
each concentration of octyl-glucoside.
P-gp reconstitution into preformed or solubilized
vesicles was achieved by slow dialysis or gel filtra-
tion to remove detergent. In each case, a saturating
concentration of detergent was added to a 20-mM
suspension of LUVs and incubated at room tempera-
ture for 10 min. Protein suspension was added to the
detergentrlipid mixture to a final protein concentra-
tion of 0.1–0.15 mgrml and incubated at 48C for 40
min. In the case of slow dialysis, the
detergentrlipidrprotein mixture was placed in a 6- to
8-kDa cut-off dialysis bag and dialysed against buffer
D for 72 h at 48C, with buffer changes every 12 h.
Removal of detergent by gel filtration was achieved
with a 1=60 cm Sephadex G-50 column equili-
brated previously with dialysis buffer D. Prior to the
initial use of each new column, the non-specific
binding sites were coated by flushing the column
with 100 mg asolectin. The proteinrlipidrdetergent
mixtures were loaded onto the column and cloudy
fractions of the void volume pooled. These proteo-
liposomes were collected by centrifugation at 150 000
=g for 2 h at 48C. The pellet was resuspended in
buffer D at a protein concentration of 0.4–0.5 mgrml.
The efficiency of reconstitution was followed by
w3 x  .inclusion of H phosphatidyl-choline 1 mCi in the
LUVs. Typically, 15–20 mg reconstituted protein
was mixed 1:1 with buffer E 100 mM K SO , 202 4
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.  .mM PIPES, pH 6.9 containing 60% wrv sucrose
and 0.05% Triton X-100 to render the liposomes
 .leaky. Buffers containing 20, 10, 5 and 0% wrv
sucrose were layered over the liposomes in 30%
sucrose and the gradients centrifuged at 150 000=g
for 4 h at 48C. The location of lipid was determined
by using 10% of each sucrose fraction for liquid
scintillation counting. A further 20–30% of each
fraction was used to assay for protein by SDS–PAGE
following precipitation with trichloracetic acid.
2.5. ATP hydrolytic acti˝ity of P-glycoprotein
The ATPase activity of P-gp in CH rB30 mem-
 .branes 1–2 mg protein or reconstituted into lipo-
 .somes 0.4–0.6 mg protein was measured by the
w xmethod of Chifflet et al. 36 . The incubation period
used was 25 min at 378C and the effects of vanadate
 y8 y5 .and verapamil 5=10 to 5=10 M on ATP
hydrolysis were assessed. Vanadate stock solutions
w xwere prepared as previously described 37 . ATPase
activity was expressed as nmol inorganic phosphate
liberated per mg of protein and plotted as a function
of added drug concentration. The potency of each
compound to alter ATPase activity of P-gp was ex-
pressed as an EC concentration dose required to50
.give 50% of maximal effect . The EC concentra-50
tions were determined from non-linear regression
w xusing the general dose–response equation 38 below:
dA s ayb r 1q Xrc qb 1 .  .  . 5 /o
where A s% basal ATPase activity; as initial AT-o
Pase activity; bs final ATPase activity; csEC50
concentration; d s slope factor; and X s
concentration of drug.
[3 ]2.6. Equilibrium binding of H ˝inblastine to
P-glycoprotein
w3 xBinding of H vinblastine to P-glycoprotein was
assessed by a rapid filtration assay based on pub-
w x r  .lished methods 16 . CH B30 membranes 20 mg , or
 .reconstituted protein 1–4 mg , were incubated with
w3 xH vinblastine in a 200-ml volume of binding buffer
 .F 0.05 M Tris HCl, pH 7.4 at 208C for 120 min.
Following incubation, 3 ml ice-cold buffer G 0.02 M
.Tris HCl, pH 7.4, 20 mM MgCl was added and the2
samples filtered through GFrF and 0.2-mm nitro-
cellulose filters presoaked with 0.1% BSA in buffer
.F to retain bound drug and subsequently washed
twice with 3 ml ice-cold buffer G. Radioactivity
associated with the filters was determined by liquid
scintillation counting. Filtration of proteoliposomes
with GFrF and 0.2-mm nitrocellulose filters retained
greater than 80% of CH rB30 membranes, but less
than 30% of proteoliposomes. However, greater than
85% of proteoliposomes were retained with a GFrF
and 0.1-mm nitrocellulose filter combination.
Saturation isotherms were generated with 0.1–100
w3 xnM H vinblastine in the absence or presence of 3
mM vinblastine, the latter indicating the level of
non-specific binding. Data were expressed as pmol of
w3 xH vinblastine bound per mg of protein. The equa-
tion below was fitted to saturation isotherms by
non-linear regression:
B s B )F r K qF 2 .  . .o max d
w3 xwhere, B samount of H vinblastine bound; Bo max
s maximum density of binding sites; K sd
dissociation constant; F s concentration of free
w3 xH vinblastine.
Displacement assays were performed with a single
w3 x  .concentration of H vinblastine 25–30 nM in the
presence of competing compound at concentrations
indicated in the figure legends. Non-specific binding
w3 x rof H vinblastine to CH B30 membranes was deter-
mined in the presence of 3 mM vinblastine. The
results for each compound were expressed as a frac-
w3 xtion of the total specific binding of H vinblastine in
the absence of competing agent. The potency of each
w3 xcompound to displace H vinblastine binding was
expressed as an EC concentration determined by50
 .non-linear regression of Eq. 1 to displacement
curves. In this case the parameters obtained were;
w3 xA s fraction total H vinblastine bound, a so
maximal binding, bsminimum binding, csEC50
concentration, dsslope factor and Xsconcentration
of competing compound.
In order to use the rapid filtration technique to
w3 xmeasure binding of H vinblastine to solubilized
P-gp, the drug–protein complex was precipitated as
w xdescribed 39 . Briefly, following the appropriate in-
cubation period, the samples were cooled to 48C in an
 .  .ice-bath. BSA 0.1 mg , g-globulin 0.1 mg and 3
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 .ml of PEG-6000 10% wrv in binding buffer F were
added to the samples and left for 40 min at 48C prior
to filtration as described above. The washing buffer
 .G contained 5% wrv PEG-6000.
2.7. Routine procedures
w xSDS-gel electrophoresis 40 and immunoblotting
w x41 were performed according to published methods.
Precipitation of dilute protein solutions by trichloro-
w xacetic acid was based on published methods 42 and
protein concentration determined with a detergent
compatible kit according to the suppliers instructions
 .BioRad, Hemel Hempstead .
3. Results
3.1. Characterization of P-glycoprotein in CH rB30
membranes
The starting material for purification of P-gp was
plasma membranes obtained from CH rB30 cells. The
activity of P-glycoprotein in its native environment
served as a reference for retention of activity during
purification as assessed by ATP hydrolysis and equi-
w3 xlibrium binding of H vinblastine. The results for
CH rB30 membranes are summarized in Fig. 1.
Equilibrium techniques were used to determine the
affinity and capacity of vinblastine binding to
r  .CH B30 membranes. The dissociation constant Kd
 .of 36.3"4.7 nM ns3, independent preparations
obtained from saturation isotherms indicates that
w3 xH vinblastine bound with high affinity. The density
w3 x rof sites for H vinblastine binding to CH B30 mem-
branes was 161"11 pmolrmg protein. If 1 mol of
 .vinblastine binds to 1 mol of P-gp M rs180 kDa
then this B translates into 2.9% of total membranemax
 .protein, which is borne out by silver staining Fig. 3 .
Non-specific binding to membranes and filters ac-
counted for 10–15% of total binding and all binding
assays were performed in hypotonic buffer to mini-
mize possible accumulation of drug in the intravesic-
ular space. Membranes from the parental cell line
AuxB1, which does not express P-gp, displayed neg-
ligible specific binding of the radioligand data not
.shown .
ATPase assays were performed in the presence of
EGTA, NaN and in the absence of Naq or Kq in3
order to minimize contributions from P-, F- and
V-type ATPases present in membranes. The basal
ATP hydrolytic activity V s897"55 nmol Pmax i
y1 y1 .min mg K s1.84"0.37 mM obtained fromm
r  .CH B30 membranes ns9 was insensitive to 2
mM ouabain. Verapamil stimulated the basal activity
 .  .2 mM ATP by a factor of 1.59"0.05 ns13
 .with high potency EC s0.60"0.21 mM . In con-50
trast, sodium orthovanadate decreased the basal AT-
 .Pase activity of P-gp by 91"8% ns9 with an
EC concentration of 1.8"0.6 mM.50
3.2. Effects of non-ionic detergents on P-glycoprotein
acti˝ity
Prior to their use for solubilization of P-gp, dode-
cyl-maltoside, octyl-glucoside and zwittergent 3–12
were examined for their effects on function. In partic-
ular, the ability of these detergents to inhibit ATPase
w3 xactivity of, and displace H vinblastine binding to
P-gp is summarized in Table 1. Complete dose–re-
sponse curves were performed in the presence or
absence of a crude bovine spinal cord phospholipid
mixture. On a molar basis, dodecyl-maltoside was the
most potent inhibitor of the ATPase activity and drug
binding by P-gp with EC values of 59"10 and50
26"7 mM, respectively. The critical micelle concen-
 .tration CMC of this detergent is 200 mM and
therefore the EC values were equivalent to 13–30%50
of the CMC. However, in the presence of excess
lipid, the EC value for inhibition of basal ATPase50
activity of P-gp was increased to 368"56 mM.
Similarly, the EC value for displacement of the50
w3 xequilibrium binding of H vinblastine to P-gp was
raised to 259"43 mM following addition of lipids.
Therefore, a crude mixture of lipids was able to
 .protect the ATPase activity 6-fold and drug binding
 .10-fold by P-gp from the deleterious effects of
dodecyl-maltoside. In both cases, the EC values50
were raised above the CMC.
The ATPase activity of P-gp was also sensitive to
the detergent octyl-glucoside with EC values of50
 .6.4"3.0 mM 40% of CMC in the absence, and
18.8"1.7 mM in the presence of spinal cord lipids.
The magnitude of protection afforded by the lipids
 .3-fold was not as large as observed for dodecyl-
w3 xmaltoside. Binding of H vinblastine to P-gp was
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also perturbed by octyl-glucoside with an EC value50
 .1.2"0.1 mM equivalent to only 8% of the CMC.
A two-fold protection against the effects of octyl-glu-
coside by excess lipids did not raise the EC value50
 .2.4"0.8 mM above the CMC for the detergent.
The zwitterionic detergent, zwittergent 3–12, was
also a potent inhibitor of ATPase activity EC s50
. 132"39 mM; 7% of CMC and drug binding EC50
.s262"73 mM; 13% of CMC associated with P-gp.
The inhibition of ATPase activity was partly reversed
w3 x r  .Fig. 1. Characterization of ATPase activity and H vinblastine binding by P-gp in CH B30 membranes. a: the effects of verapamil I
 .  .  .and orthovanadate v on ATPase activity of membranes 1 mg in the presence of 2 mM MgATP. Data mean"S.E.M. are expressed
w3 x ras a percentage of ATPase activity in the absence of drug. b: saturation isotherm for H vinblastine binding to CH B30 membranes.
w3 x  .H Vinblastine 1–80 nM was incubated with 20 mg membrane at 238C for 2 h before bound and free ligand were separated by rapid
filtration. Non-specific binding was defined as the amount of ligand bound in the presence of 3 mM excess cold vinblastine and was linear
w3 xas a function of H vinblastine concentration. The data shown were obtained from a single representative experiment and parameters
 .  ."asymptotic S.E. obtained from curve fitting as described in Section 2 Materials and methods were: K s21"2 nM andd
B s103"4 pmolrmg.max
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Table 1
 .The ability of bovine spinal cord lipids to protect against the effects of the non-ionic detergents 1 nM–0.1 M dodecyl-maltoside,
w3 x roctyl-glucoside and zwittergent 3–12 on the ATPase activity and H vinblastine binding properties of P-gp in CH B30 plasma
membranes
Dodecyl-maltoside Octyl-glucoside Zwittergent 3–12
ATPase Binding ATPase Binding ATPase Binding
 .  .  .  .  .  .mM mM mM mM mM mM
Control 59"10 26"7 6.4"3.0 1.21"0.06 132"39 262"73
0.2% lipid 368"56 259"43 18.8"1.7 2.44"0.75 444"98 269"77
Fold protection 6.2 10.1 2.9 2.0 3.4 1.0
P-value -0.01 -0.01 -0.01 -0.05 -0.01 n.s.
 .Results shown are the mean EC values "S.E.M. obtained from 3–5 plasma membrane preparations.50
by the addition of spinal cord lipid EC s444"9850
.mM; 3.4-fold increase . However, lipids did not pro-
w3 xtect P-gp against the displacement of H vinblastine
 .binding EC s269"77 mM caused by zwitter-50
gent 3–12.
In summary, all three detergents inhibited ATPase
activity and drug binding by P-gp to varying degrees.
However, the potencies did not vary significantly
when expressed as a percentage of CMC. Further-
more, the two activities measured displayed different
sensitivities to detergent in the absence or presence of
added lipid. Solubilization of integral membrane pro-
teins usually requires detergent concentrations signif-
icantly greater than the CMC. Of the detergents
tested only dodecyl-maltoside-induced inactivation of
P-gp occurred at values above the CMC in the pres-
ence of excess lipid.
[ 3 ]3.3. Binding of H ˝inblastine to detergent
solubilized P-glycoprotein
In the previous section, the ability of lipids to
protect against P-gp inactivation by detergent was
assessed. To assess whether the inactivation was
reversible, P-gp was solubilized by detergent in the
absence of added lipids and saturation isotherms per-
w3 xformed to examine H vinblastine binding. P-gp
w3 x bound H vinblastine with a K s130"9 nM nsd
.  .3 , a significant reduction 3.6-fold in affinity from
r  .CH B30 membranes Fig. 4 . Furthermore, the bind-
ing capacity of P-gp was reduced approximately 6-
fold from CH rB30 membranes to 25"9 pmolrmg
protein.
To examine whether the inhibition of drug binding
capacity of soluble P-gp by detergent could be re-
versed, crude spinal cord lipids were added to the
solubilized protein. Fig. 2 shows that binding of
w3 xH vinblastine to solubilized P-gp was increased by
3.5"0.4-fold with an EC value of 0.33"0.12%50
 .wrv . Maximal recovery of activity was obtained at
 .approximately 8 mgrml 0.8% wrv lipid. P-gp was
solubilized with 4 mgrml dodecyl-maltoside which
is equivalent to a lipidrdetergent ratio of 2, roughly
the R value for dodecyl-maltoside see Sectionsol
.3.6 . The R value is the ratio of lipid and detergentsol
w3 xFig. 2. Reversibility of the detergent-impaired H vinblastine
binding to solubilized P-gp. P-gp from CHrB30 membranes was
 .solubilized with 0.4% wrv dodecyl-maltoside. Specific binding
w3 x  .of 25–30 nM H vinblastine to soluble protein 10 mg was
determined using a rapid filtration assay. Non-specific binding in
the presence of 3 mM cold vinblastine was subtracted from total
binding. Sonicated bovine spinal cord lipids were added at the
concentrations indicated and the results expressed as a fraction of
binding in the absence of added lipid. All data points are the
mean"S.E.M. from three independent preparations.
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at which lipids are in the micellar form. Under these
conditions, lipids will saturate the proteinrdetergent
micelles and maximally protect activity. At higher
lipidrdetergent ratios, added lipids will begin to form
liposomes.
Therefore, besides preventing inactivation of P-gp
in the presence of dodecyl-maltoside, the addition of
excess lipids may convert some P-gp from a confor-
w3 xmation which cannot bind H vinblastine, to a con-
formation with higher binding capacity.
3.4. Purification of P-glycoprotein from CH rB30
membranes
P-Glycoprotein was considered to be fully solubi-
lized by the detergent dodecyl-maltoside since cen-
trifugation at 100 000=g did not pellet the protein.
 .A concentration of 0.4% wrv dodecyl-maltoside
solubilized greater than 90% of P-gp and approxi-
mately 50% of total membrane protein see Fig. 3
.and Table 2 thereby resulting in a two-fold enrich-
ment. A crude mixture of sonicated bovine spinal
cord lipids was included during solubilization to pre-
serve drug binding and ATPase activity of P-gp see
.above . The use of anion exchange as a first chro-
matographic step necessitated the use of a low ionic
strength buffer for the solubilization step. Efficiency
of solubilization was unaffected in the pH range
6.0–7.5. However, profound effects on chromatogra-
phy were observed. At pH 7.4, all the P-gp bound to
the anion-exchange resin, eluting at 180–200 mM
NaCl. In contrast, at pH 6.9, P-gp eluted quantita-
tively in the void volume. The chromatographic reso-
Table 2
Constants obtained from solubilization of LUVs composed of
 .  .asolectin, PCrPA 95:5 and bovine spinal cord BSC lipids by
octyl-glucoside
Lipid composition Saturation Solubilization
R D R Dsat w sol w
Asolectin 1.1 8 1.5 20
 .PCrPA 95:5 1.1 18 4.4 22
BSC 1.1 18 3.3 22
Constants were obtained by linear regression of the equation
w x w x w xOG s D q R Lipid to plots of OG required for saturation orw
solubilization of LUVs vs. amount of lipid. D is the monomericw
 .concentration mM and R is the ratio of detergent to lipid at
saturation or solubilization.
Fig. 3. SDS–PAGE analysis of protein at each stage of P-gp
purification. Proteins were separated by electrophoresis on 7.5%
SDS–PAGE gels and detected by silver staining. Lanes from left
. rto right : CH B30 membranes; membrane proteins solubilized by
 .0.4% wrv dodecyl-maltoside; insoluble material; proteins ob-
tained in void volume of the anion-exchange column; and puri-
fied P-gp obtained from the hydroxy-apatite column. Each lane
contained 2 mg protein.
lution of P-gp was similar at either pH data not
.shown . An approximately 4-fold purification of P-gp,
based on protein yield, was achieved using the
anion-exchange step. Fractions containing P-gp were
 .concentrated into smaller volumes -1 ml to enable
efficient loading on an hydroxy-apatite column 1 ml
.bed volume . It was necessary to use 100-kDa cut-off
membranes to prevent concentration of dodecyl-
maltoside which has a micelle molecular weight of
50-kDa. Low recovery of P-gp was observed from
hydroxy-apatite columns at pH values over 7.0, due
to irreversible binding to the matrix. Increased recov-
ery of protein was achieved by lowering the pH to
6.6. P-gp eluted from the matrix at phosphate concen-
trations between 200 and 250 mM and, based on
protein yield, this chromatographic step resulted in a
5- to 6-fold purification. Approximately 100 mg of
P-gp was obtained from 5 mg of CH rB30 mem-
branes, a 45-fold purification. Fig. 2 illustrates the
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relative purity of P-gp at each stage of the purifica-
tion and the final product was estimated to be of 90%
purity.
3.5. Acti˝ity of soluble P-glycoprotein during
purification
w3 xThe H vinblastine binding capacity of soluble
P-gp was used to assess its functional state at each
 .stage of purification Fig. 4 . The decrease in
w3 xH vinblastine binding to P-gp following solubiliza-
tion in dodecyl-maltoside, outlined above, was also
observed for the detergents octyl-glucoside B smax
. 8.9"1.4 pmolrmg and zwittergent 3–12 B smax
.17.2"7.7 pmolrmg . Therefore, it appears that the
impaired drug binding capacity of solubilized P-gp is
not confined to any one detergent. Rather it is a
consequence of removing the protein from its native
lipid environment.
Subsequent anion-exchange chromatography under
conditions where P-gp was bound by the matrix pH
.7.4 further inactivated the protein. Despite the 4-fold
purification during this step, the binding capacity of
soluble P-gp was actually reduced by 4-fold to 5.8"
w3 x  .Fig. 4. Scheme outlining the ability of P-gp to bind H vinblastine during purification. Binding capacity B of P-gp was determinedmax
 w3 x .from saturation isotherms 1–150 nM H vinblastine obtained by a rapid filtration assay as described in Section 2: Materials and
r  .  .  .methods. Initially, CH B30 membranes were solubilized by 1.25% wrv octyl-glucoside, 0.4% wrv dodecyl-maltoside or 1.0% wrv
 .zwittergent and binding assays performed on soluble protein 10 mg . Protein solubilized by dodecyl-maltoside was subjected to
anion-exchange chromatography at either pH 6.9 or 7.4 and binding assays performed on 5 mg pooled P-gp-containing fractions.
 .Saturation isotherms were also obtained for P-gp-containing fractions 1–2 mg protein following hydroxy-apatite chromatography.
Binding capacity was obtained from the mean of 2–3 independent determinations using non-linear regression analysis.
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0.4 pmolrmg. However, if anion-exchange chro-
matography was performed at pH 6.9, the binding
capacity of P-gp increased to 44"15 pmolrmg. An
increase in binding capacity B s 59 " 19max
.pmolrmg , although not in proportion to the increase
 .in purity 5-fold , was also observed following hy-
droxyl-apatite chromatography. These results demon-
strate that allowing P-gp to interact with the anion-
exchange matrix caused a significant reduction in the
ability of the protein to bind substrate. Thus, the
purification scheme resulting in the most functional
form of P-gp employed anion-exchange chromatogra-
phy at pH 6.9. There was no advantage gained by
solubilizing P-gp in either octyl-glucoside or zwitter-
gent 3–12. This is in agreement with data outlined in
the section above describing effects of detergents on
P-gp activity in native membranes.
3.6. Liposome solubilization by octylglucoside and
reconstitution of P-gp
P-gp was reconstituted into liposomes composed
of asolectin lipids using the detergent octylglucoside.
Octylglucoside was chosen since the low CMC of
 .dodecyl-maltoside 0.2 mM prevented easy removal
by dialysis techniques.
To investigate the interaction between unilamellar
liposomes and octyl-glucoside, solubilization profiles
were performed. The solubilization of unilamellar
 .asolectin liposomes 5–25 mM was examined by
following the change in light scattering caused by
 .intact liposomes Fig. 5a . The initial point of inflec-
tion occurred at the maximal concentrations of octyl-
glucoside tolerated by the liposome and was defined
w xas OG . At higher concentrations of octylglucosidesat
solubilization progressed to the point where light
scattering was negligible, reflecting mixed micelles
w xof lipid–detergent 43 . This was defined as the solu-
w x .bilizing OG concentration of octylglucoside.sol
w x w xValues of OG and OG were plotted as asat sol
function of phospholipid concentration and linear
w xrelationships obtained of the form OG sD qw
w x  .R Lipid Fig. 5b . D corresponds to the monomericw
concentration of detergent and R is the ratio of
detergent to lipid in the liposomes. Solubilization of
asolectin liposomes by octylglucoside was described
w x w x by the relationship OG s19.9q1.54 Lipid rssol
Fig. 5. Solubilization of unilamellar liposomes composed of
asolectin by the detergent octyl-glucoside. a: representative curves
  .  .  .  ..of liposome 5 = , 10 ^ , 15 ‘ and 22.5 mM B
solubilization by increasing concentrations of octyl-glucoside as
evidenced by light scattering at 750 nm in a 500 ml reaction
volume. b: concentrations of octyl-glucoside resulting in satura-
w x . w x .tion OG , B and solubilization OG , ‘ of liposomessat sol
were plotted as a function of lipid concentration. The linear
w xrelationships obtained were defined by the expressions OG ssat
w x  . w x7.6q1.2 Lipid r s 0.949, n s 13 and OG s 19.9qsol
w x  .1.5 Lipid r s0.961, ns15 . These data were obtained at 8
different lipid concentrations from several independent experi-
ments.
. w x0.961, ns15 and saturation by OG s7.61qsat
w x  .1.17 Lipid rs0.949, ns13 . The concentrations
of octyl-glucoside required to saturate or completely
solubilize a given concentration of asolectin lipo-
somes may be estimated from these relationships.
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The relatively low level of R for octylglucosidesol
solubilization compared with previous reports using
model lipid systems prompted further investigation.
Table 2 shows the values of R , R and thesat sol
respective D obtained for solubilization of asolectin,w
bovine spinal cord lipids and liposomes composed of
 .egg phosphatidylcholine and phosphatidic acid 95:5
by octyl-glucoside. Interestingly, significantly higher
octylglucoside concentrations were required to solu-
bilize liposomes composed of crude spinal cord or
defined lipid species. The lower R value ofsol
asolectin lipids appears peculiar to this complex lipid
mixture rather than a general octylglucoside–lipid
phenomenon.
In order to reduce the exposure of P-gp to deter-
gents, reconstitution was performed using liposomes
w xsaturated with 35 , rather than completely solubilized
by octylglucoside as in conventional methods. Pure
P-gp had been concentrated to approximately 0.4
mgrml and liposome suspensions made at 15 mgrml.
Therefore, to reconstitute at a lipidrprotein ratio of
100, the protein solution was diluted roughly 3-fold
corresponding to a dodecyl-maltoside concentration
in the final proteinrlipidrdetergent mixture of
 .0.007% wrv . Since the CMC for dodecyl-malto-
 .side is 0.01% wrv , following dilution the
micellermonomer equilibrium of the proteinr lipidr
detergent mixture was shifted towards the monomeric
form of dodecyl-maltoside. The monomeric dodecyl-
maltoside was then removed by dialysis.
P-gp reconstitution using Sephadex chromatogra-
phy was used initially since there is a significantly
shorter contact time between detergent and protein
compared with conventional dialysis. Lipid recover-
ies greater than 80% were typically achieved, al-
though, 40–50% of the protein was lost during chro-
matography. Consequently, for reconstitution of the
post hydroxy-apatite fraction, slow dialysis was the
preferred method due to the relatively smaller amounts
of protein available.
The efficiency of P-gp reconstitution was assessed
by migration profiles of liposomes and protein through
 .sucrose gradients during centrifugation Fig. 6 . There
were two major lipid bands: the first floating upwards
through the gradient to 0% sucrose; however, this did
not contain protein; the second and major band
spanned the interface between 5 and 10% sucrose.
Fig. 6. Efficiency of P-gp reconstitution into preformed unilamel-
lar liposomes saturated with octyl-glucoside. Following dialysis,
the lipidrprotein mixtures were centrifuged at 150000= g
through a discontinuous sucrose gradient as described in Section
2: Materials and methods. Localization of lipids was assessed by
w3 xmigration of tracer amounts of H phosphatidyl-choline through
the gradient. The amount of lipid in each sucrose fraction were
expressed as a percentage of total phospholipid. The inset shows
localization of purified P-gp in the sucrose gradient fractions.
Protein was determined by immuno dot-blotting using the mono-
clonal antibody C219.
This band contains greater than 90% of the P-gp and
is evidence of reconstitution. Confirmation of recon-
stitution of P-gp into these liposomes is two-fold.
Firstly, electron microscopic images demonstrate in-
w xsertion of P-gp into liposomes 44 . Secondly, if pure
P-gp was centrifuged through sucrose gradients in the
absence of lipid, the protein did not migrate out of
 .the 30% sucrose fraction data not shown . Using a
vesicle radius of 100 nm and an approximate phos-
2 w xpholipid surface area of 50 nm 45 the estimated
number of P-gp molecules per liposome was 1–1.5.
Similar results were obtained under reconstitution
conditions employing solubilizing concentrations of
 .octyl-glucoside data not shown . In the less pure
post-solubilization and anion-exchange stages of pu-
rification, greater than 90% of the P-gp was also
associated with the liposomes.
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3.7. Acti˝ity of purified P-glycoprotein reconstituted
into asolectin liposomes
Protein obtained at each stage of purification was
reconstituted into asolectin liposomes at lipidrprotein
ratios of 70–100 by weight, equivalent to a molar
lipidrprotein ratio of 14 000–20 000. The ATPase
w3 xand H vinblastine binding activities of reconstituted
P-gp are shown in Table 3.
ATPase activity of reconstituted protein was per-
formed at several concentrations of ATP in order to
determine the maximal rate of hydrolysis and the
affinity for ATP. The K for ATP hydrolysis by P-gpd
r  .in CH B30 membranes 1.8"0.4 mM was not sig-
 .nificantly altered during purification Table 3 reflect-
ing an unchanged affinity for the nucleotide. The Vmax
for ATP hydrolysis by P-gp increased from 897"55
nmol miny1 mgy1 in CH rB30 membranes to a value
y1 y1  .of 2137"309 nmol min mg ns4 for the
purified, reconstituted protein. This represents the
highest reported rate of ATP hydrolysis by purified
P-gp to date. However, the proportional increase in
specific ATPase activity for each fraction did not
quantitatively match the degree of purification. Solu-
bilization of P-gp from CH rB30 membranes with
dodecyl-maltoside, despite a two-fold enrichment in
P-gp, did not increase the V . The initial solubiliza-max
tion step contains the highest detergent concentration
 .0.4% wrv during the procedure and therefore some
loss in activity is not surprising. In contrast, hy-
 .droxyl-apatite chromatography 5-fold purification
during which detergent concentration was reduced to
 .0.02% wrv resulted in a 2-fold increase in V .max
The lack of quantitative agreement between purifica-
tion and specific activity was due to a combination
 .of: a the presence of contaminating ATPases in the
 .less pure earlier fractions; and b partial inactivation
of P-gp during the purification.
As reported earlier, the ATPase activity of P-gp in
its native membrane is sensitive to verapamil and
orthovanadate. Full dose–response relationships for
 .ATPase activity 2 mM ATP in the presence of
either verapamil or orthovanadate were carried out at
each stage of purification. The concentrations at which
half-maximal effect occurred were estimated by non-
linear regression and are shown in Table 3. Vera-
pamil, retained the ability to stimulate the ATPase
 .activity of P-gp range 1.3- to 1.8-fold at each stage
of purification. The degree of stimulation by vera-
pamil did not significantly differ between any stage
of purification and the native membranes, reflecting
correct coupling of drug–protein interaction and AT-
Pase activity. However, the EC value of 4.86"1.1650
mM obtained for purified reconstituted protein was
higher than in CH rB30 membranes. Similarly, higher
concentrations of verapamil were required to cause
50% stimulation of the ATPase activity of P-gp
 .reconstituted from the solubilized 1.4"0.5 mM ,
Table 3
ATPase activity and vinblastine binding by P-gp during the course of purification
CHrB30 membranes Solubilized protein Anion exchange Hydroxy-apatite
Protein
 .Amount mg 5000 2380 580 107
Purification 1.0 2.1 8.2 45
ATPase activity
 .K ATP 1.82"0.37 2.19"0.47 2.19"0.26 2.79"0.51m
y1 y1  .V ATP nmol min mg 897 "55 926 "30 1129 "179 2137 "309max
 .  .EC verapamil mM 0.61"0.25 1.25"0.62 4.29"1.45 2.91"0.9650
 .  .EC vanadate mM 1.52"0.55 1.95"0.85 2.92"1.47 3.13"0.7750
3w xH Vinblastine binding
 .K nM 36"5 62"12 57"13 64"9d
 .B pmolrmg 161"11 404"81 807"117 2320"192max
w3 x rATPase activity and H vinblastine binding were determined for CH B30 membranes and P-gp at various stages of purification. P-gp
 .was reconstituted into asolectin LUVs at lipidrprotein ratios of 100 wrw . All values are the mean"S.E.M. obtained from 3–5
independent preparations.
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 .and post anion-exchange fractions 5.6"0.7 mM .
The ATPase activity of P-gp was inhibited at each
stage of purification by sodium orthovanadate with
complete inactivation at concentrations of 100–150
mM. The EC values for inhibition of ATP hydroly-50
sis by vanadate were not significantly different be-
r  .tween CH B30 membranes 1.5"0.6 mM, ns5
and purified reconstituted P-gp 3.1"0.8 mM, ns
.5 .
To date, there has been no quantitative assessment
of substrate binding to purified P-gp. We examined
the protein–ligand interaction using equilibrium bind-
ing techniques to measure the affinity and capacity of
w3 xthe H vinblastine–P-gp interaction. Saturation
w3 xisotherms were carried out for H vinblastine bind-
ing to reconstituted protein each stage of purification.
Following solubilization in dodecyl-maltoside and re-
constitution into asolectin liposomes, P-gp bound 404
 ."81 pmolrmg ns4 with a K s62"12 nM.d
The affinity was not significantly different from that
in native membranes K s36"5 nM, B s161d max
."11 pmolrmg and the 2.5-fold increase in capacity
quantitatively agreed with the degree of purification.
In contrast, soluble P-gp bound 16-fold less
w3 x  .H vinblastine with a K s130"9 nM Fig. 4 .d
This suggests that P-gp has a strict requirement for
the presence of phospholipids to bind substrate with
high affinity. The specific binding capacity of P-gp
increased as the protein was further purified. High
w3 x  .affinity binding of H vinblastine K s64"9 nMd
was retained by purified reconstituted P-gp. The bind-
 .ing capacity of pure P-gp 2320 pmolrmg was
15-fold higher than observed in CH rB30 membranes.
Based on the B observed in CH rB30 membranes,max
the theoretical maximum binding capacity of purified
P-gp is estimated at 7245 pmolrmg protein. Assum-
w3 xing that 1 mol of H vinblastine binds to 1 mol of
P-gp, and accepting that P-gp has been purified to
homogeneity, 35–40% of P-gp retains this biological
activity.
Reconstitution with a large excess of lipids such as
employed in the present manuscript makes it difficult
to assay transport of typical P-gp substrates such as
vinblastine due to their inherent hydrophobicity and
therefore avid partitioning into the lipid environment.
Successful reconstitution at significantly lower
lipidrprotein ratios will allow accurate measurement
of drug transport by P-gp.
4. Discussion
To date, protocols for purification of P-gp have
resulted in protein with a poor specific activity com-
pared with starting material and in some cases low
yield. In the present study we have quantitatively
assessed the ATPase activity and drug binding capac-
ity of P-gp throughout its purification in order to
determine conditions under which maximal function
was retained. P-gp was shown to be most susceptible
to inactivation under conditions that perturb the
lipid–protein interface. The purified, reconstituted
protein displayed the highest ATPase activity re-
ported thus far and high affinity binding of vinblas-
tine.
The basal P-gp ATPase activity of the starting
material for purification, CH rB30 membranes, dis-
played similar pharmacological characteristics to the
r w xwell-characterised CH C5 cell line 22 . Furthermore,
the high affinity binding of vinblastine to hamster
P-gp obtained using equilibrium techniques in the
present study was similar to that reported for human
w xP-gp 18 . Drug binding to P-gp was assessed using
equilibrium techniques which, unlike labeling with
photo-affinity compounds, permit quantitation of the
affinity and capacity of binding. Furthermore, the use
of a photo affinity ligand, such as azidopine, to
 .examine drug binding to P-gp is limited by: 1 low
 .affinity compared with vinca alkaloids; 2 the large
 .number of orientations the molecule may assume; 3
the reactive azide may not reside in the pharma-
w x  .cophoric region 46 ; and 4 only binding displace-
ment data is possible.
The key first step in purification of integral mem-
brane proteins is extraction from the membrane envi-
ronment whilst retaining function. Extraction from
the membrane involves the use of ampiphilic com-
w xpounds, usually detergents. CHAPS 22 , octyl-
w x w xglucoside 23 , zwittergent 3–12 25 and dodecyl-
 .maltoside this study have previously been used to
solubilize P-gp. One would expect that ampiphiles
such as these detergents would perturb the lipid–pro-
w xtein interface 47 . Indeed, it has been demonstrated
that membrane protein function is inactivated under
conditions where even a small fraction of annular
w xlipids are displaced 48,49 . This was evident in the
present study since all the non-ionic detergents exam-
ined were able to inactivate P-gp at concentrations
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well below their respective CMC values. The inacti-
vation of P-gp function by detergents was both pre-
ventable and partly reversible if an excess of phos-
pholipids was present. This ‘protective’ effect may
 .be explained by either: 1 partitioning of detergent
between added lipids and P-gp containing mem-
 .branes; or 2 direct protection of protein activity,
perhaps by increasing lipid content at the annulus.
Irrespective of the precise mechanism, not all the
detergents behaved similarly. For example, greater
functional protection was observed for dodecyl-
maltoside compared with the related detergent octyl-
glucoside. It has previously been reported that deter-
gents with longer alkyl chain length, such as on
dodecyl-maltoside, may protect the hydrophobic por-
tion of integral membrane proteins to a greater extent
than shorter 8-carbon alkyl chain detergents like
w xoctylglucoside 48,50 . However, despite having a
12-carbon alkyl chain, zwittergent 3–12 remained a
potent inactivating agent even in the presence of
excess phospholipids in the present study. This appar-
ent inconsistency may be explained by the inability
of detergents, such as zwittergent 3–12, dodecyl-di-
methyldiamine oxide and the Tween series, to ade-
quately segregate hydrophobic a-helices from the
aqueous environment due to their bulky head groups
w x50 . In the present study, the conditions which pre-
serve both substrate binding and ATPase activity of
P-gp to the greatest degree involve the use of dode-
cyl-maltoside and an excess of crude lipids.
Following extraction from its native environment,
solubilized P-gp displayed a markedly reduced affin-
ity and capacity to bind vinblastine. This impaired
substrate binding was independent of the detergent
used. There is a large body of evidence indicating
that agents which perturb plasma membrane biophys-
ical properties are able to modify the activity of P-gp
w x30,31,51 . The results obtained from the present
study suggest that the mechanism by which mem-
brane-active agents affect P-gp involves disruption of
a protein–phospholipid interface which transforms
P-gp into a conformation that binds vinblastine with
low affinity. Binding of solubilized P-gp to an
anion-exchange matrix also led to decreased affinity
and substrate binding capacity of P-gp. It has previ-
ously been shown that the ATPase activity of P-gp
was damaged following binding to other chromato-
w xgraphic matrices 27 . Phospholipids may also bind to
anion-exchange media, and therefore the possibility
w xof disrupting lipid–protein interactions exists 32 ; a
property which has been used to generate delipidated
w xprotein 48 . Such delipidation of P-gp would impair
its function in a manner analogous to the use of high
detergent concentrations.
To date, P-gp has been reconstituted following
removal of detergent from protein–detergent and de-
tergent–lipid micelles by dialysis, dilution or gel
w xfiltration chromatography 22,24,25 . Reconstitution
of proteins from mixed micelles has several draw-
 .backs including: 1 the use of high detergent concen-
 .trations to generate phospholipid micelles; 2 no
control of the size of proteoliposomes formed follow-
 .ing detergent removal; and 3 symmetric orientation
of proteins into liposomes. Several, integral mem-
 .brane proteins e.g., bacteriorhodopsin have been
reconstituted into preformed liposomes mildly dis-
w xrupted by detergents or fusogenic agents 35,52 . We
have demonstrated for the first time that P-gp is
efficiently reconstituted into preformed unilamellar
liposomes containing only saturating concentrations
of octylglucoside. Higher ATPase activity and drug-
binding capacity were obtained than following recon-
stitution into mixed micelles of solubilized phospho-
lipid, presumably due to the lower detergentrprotein
w xratios 44 . Lipids used during solubilization and for
reconstitution comprised either crude bovine spinal
 .cord extract or asolectin 30–35% PC in order to
retain any specific lipid requirements for P-gp. It has
previously been shown that addition of various lipids
to solubilized P-gp has a variety of specific effects on
w xATPase activity 26 and lipid composition modified
the basal and drug-stimulated characteristics of re-
w xconstituted P-gp ATPase activity 24 .
Reconstitution of soluble P-gp into phospholipid
bilayers at various stages of purity resulted in the
restoration of high affinity substrate binding by the
protein. In contrast to most of the previous purifica-
tion procedures for P-gp, the final product displayed
specific activity significantly greater than that of the
starting material. Approximately 40% of the total
vinblastine binding capacity of P-gp was recovered
following purification. From the present study, it also
appears that the ATPase activity of P-gp approxi-
.mately 20% retained is more sensitive to inactivation
than is drug binding. Binding of substrate has a
specific requirement for a lipid–protein interface
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which concurs with reports that substrate interacts
w xdirectly with P-gp through the lipid environment 14 .
Furthermore, the ATPase activity of P-gp was sensi-
tive to perturbations of the protein–lipid interface.
ATP hydrolysis occurs in the soluble nucleotide bind-
ing domains which one would expect to be relatively
insensitive to membrane perturbation. Transmem-
brane helices have in the past been thought to play a
passive role, merely maintaining hydrophobic interac-
tion with membrane lipids. However, it is clear that
the amphipathic nature of a-helices in integral mem-
brane proteins modulate anchoring, helix–helix inter-
actions, ligand binding and an aqueous pore in the
w xcase of ion channels 53 . The transmembrane helices
of P-gp may also be involved in generating transport
by correct coupling of substrate binding and ATP
hydrolysis.
In summary, we have developed an improved pu-
rification procedure for P-gp generating high protein
yield, a specific activity significantly increased over
levels in the starting material, whilst retaining similar
pharmacological characteristics. The generation of
this purification scheme demonstrated that disruption
of the lipid–protein interface led to both impaired
ATPase activity in conjunction with reduced affinity
and capacity for drug binding.
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